Biosimilar Savings Calculator

The 2025 Biosimilar Revolution

"Biologics" are powerful drugs grown from living cells (unlike chemical pills), making them incredibly expensive to manufacture. A "Biosimilar" is essentially a Generic for these complex drugs—highly similar in structure and function, but available at a fraction of the cost once the original patent expires.

Understanding "Interchangeability"

Some biosimilars (like Wezlana) are designated as Interchangeable by the FDA. This means they have passed rigorous switching studies proving they can be automatically substituted at the pharmacy counter without needing a new prescription from your doctor—just like swapping Tylenol for generic Acetaminophen.

Deep Dive: Stelara vs. Wezlana

The biggest shift in 2025 is the arrival of biosimilars for Stelara (Ustekinumab), a blockbuster drug used for Crohn's Disease, Ulcerative Colitis, and Psoriasis.

Old
Stelara (The Brand)Costs ~$13,500 per dose. Total annual cost can exceed $80,000.
New
Wezlana (The Biosimilar)Offers the exact same efficacy. Expected to launch at 60-85% lower cost.

The "Mark Cubans" of Pharma

New disruptors like Cost Plus Drugs are bypassing traditional insurance middlemen (PBMs). By selling biosimilars directly to consumers at "Cost + 15%", they are often offering cash prices that arelower than a patient's insurance co-pay for the brand name drug. Always double-check cash prices before using insurance.

Frequently Asked Questions

Is a biosimilar exactly the same as the brand name?

Not "identical" like a chemical generic, but "highly similar." Because biologics are grown from living cells, minor batch variations occur. However, the FDA requires biosimilars to have no clinically meaningful differences in safety, purity, or potency. You will not notice a difference in how it works.

Will my insurance force me to switch?

Likely, yes. This is called "Step Therapy" or "Non-Medical Switching." Insurance companies often prefer the cheaper biosimilar on their formulary. If you refuse and stick to the Brand Name (e.g., Humira), you may be forced to pay the full price or a much higher co-pay.

What is an 'Interchangeable' biosimilar?

An Interchangeable biosimilar has undergone extra testing to prove you can switch back and forth between it and the reference drug safely. Pharmacists can substitute these automatically without calling your doctor, just like swapping Advil for generic Ibuprofen. Wezlana is interchangeable for Stelara.

Are biosimilars safe for autoimmune diseases?

Yes. Millions of doses of biosimilars (like Inflectra for Remicade) have been administered safely over the last decade in Europe and the US. Studies confirm they are just as effective for Rheumatoid Arthritis, Crohn's, and Psoriasis.

How much is Wezlana vs Stelara?

While Stelara can cost upwards of $13,000 per dose (wholesale), Wezlana and other biosimilars are expected to launch at a 50-85% discount. For a patient taking 6 doses a year, this represents a drop from ~$80,000/year to ~$30,000/year in total health spend.

Tools & Data Verified by the EverydayCalculators Medical Research Team.

Last updated: January 2026.

Income & Tax

Real Estate & Auto

Retirement

Diet & Metabolism

Body Composition

Pregnancy & Fertility

Clinical & Lifestyle

Military Standards

The 2025 Biosimilar Revolution

Understanding "Interchangeability"

Deep Dive: Stelara vs. Wezlana

The "Mark Cubans" of Pharma

Frequently Asked Questions